WHO Press conference (embargoed)
Press Conference Announcement
Launch of WHO’s HIV drug resistance report 2017 - Under embargo until 4:00 p.m., 20 July
To get the Report under embargo
To get the Report under embargo
WHO releases new data on increasing HIV drug resistance trends in several countries that could undermine progress in preventing and treating HIV. WHO is responding with new guidelines and a global action plan to prevent and tackle HIV drug resistance.
Dr Gottfried Hirnschall, Director, Department of HIV and Global Hepatitis Programme, WHO Dr Meg Doherty, Coordinator ,HIV treatment and care, WHO Dr Silvia Bertagnolio, Medical officer, HIV treatment and care, WHO
email: Oyuntungalag (Tunga) NAMJILSUREN, at : namjilsurent@who.int Or Fadéla CHAIB at chaibf@who.int
Dr Gottfried Hirnschall, Director, Department of HIV and Global Hepatitis Programme, WHO Dr Meg Doherty, Coordinator ,HIV treatment and care, WHO Dr Silvia Bertagnolio, Medical officer, HIV treatment and care, WHO
email: Oyuntungalag (Tunga) NAMJILSUREN, at : namjilsurent@who.int Or Fadéla CHAIB at chaibf@who.int
